On this episode of Stock Movers:
- Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company’s “aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.”
- Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

On this episode of Stock Movers: - Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company&rsquo;s &ldquo;aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.&rdquo; - Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/83dedd8e-fb4d-4e0b-8462-b2f000eca4fe/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Mover

- Apple (AAPL) named hardware chief John Ternus as the iPhone maker’s next leader, with Chief Executive Officer Tim Cook shifting to the role of executive chairman. Ternus, 50, will become CEO on Sept. 1, the company said in a statement Monday. The Apple veteran was head of hardware engineering since 2021 and has spent 25 years focused on product development at the iPhone maker. Bloomberg News previously reported that Ternus was Cook’s heir apparent. Shares slipped afterhours.

- Amazon (AMZN) is investing an additional $5 billion in Anthropic, and may inject $20 billion more over time, a deal that deepens the companies’ ties in an increasingly competitive artificial intelligence industry. Anthropic, which makes the Claude chatbot and coding tool, plans to spend more than $100 billion over the next 10 years on Amazon’s cloud technologies and chips, the companies said in a statement on Monday. Amazon shares gained more than 3% on the news in after-hours trading.

- Compass Pathways (CMPS) as well as shares of other psychedelic-linked companies surged in trading after President Donald Trump signed an executive order to expedite research and access. The new order directs the US Food and Drug Administration to issue expedited review vouchers to psychedelics with a so-called breakthrough designation, shortening the review time to one to two months from six to ten months. AtaiBeckley, Definium and Compass Pathways all have therapies with breakthrough status.

Today's biggest winners and losers in the stock market.
On this episode of Stock Mover
- Apple (AAPL) named hardware chief John Ternus as the iPhone maker&rsquo;s next leader, with Chief Executive Officer Tim Cook shifting to the role of executive chairman. Ternus, 50, will become CEO on Sept. 1, the company said in a statement Monday. The Apple veteran was head of hardware engineering since 2021 and has spent 25 years focused on product development at the iPhone maker. Bloomberg News previously reported that Ternus was Cook&rsquo;s heir apparent. Shares slipped afterhours.
- Amazon (AMZN) is investing an additional $5 billion in Anthropic, and may inject $20 billion more over time, a deal that deepens the companies&rsquo; ties in an increasingly competitive artificial intelligence industry. Anthropic, which makes the Claude chatbot and coding tool, plans to spend more than $100 billion over the next 10 years on Amazon&rsquo;s cloud technologies and chips, the companies said in a statement on Monday. Amazon shares gained more than 3% on the news in after-hours trading.
- Compass Pathways (CMPS) as well as shares of other psychedelic-linked companies surged in trading after President Donald Trump signed an executive order to expedite research and access. The new order directs the US Food and Drug Administration to issue expedited review vouchers to psychedelics with a so-called breakthrough designation, shortening the review time to one to two months from six to ten months. AtaiBeckley, Definium and Compass Pathways all have therapies with breakthrough status.

Apple Slips on CEO Shakeup, Amazon Falls, Compass Pathways Soars 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c2572b8d-746c-4dbf-8453-b43201648e6d/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- USA Rare Earth (USAR) rose after the company agreed to acquire Brazil’s Serra Verde Group in a $2.8 billion cash-and-stock transaction, marking one of the largest deals in the rare-earths industry. 

- Psychedelic-linked firms like Compass Pathways (CMPS) skyrocketed after President Trump signed a weekend executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53% while AtaiBeckley surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% — touching its highest intraday level since July 2023.

- AST SpaceMobile (AST) shares dropped as much as 14% after Blue Origin’s flagship New Glenn rocket failed to correctly place a satellite made by the Texas-based company in its intended orbit.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:&nbsp;
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.
- USA Rare Earth (USAR) rose after the company agreed to acquire Brazil&rsquo;s Serra Verde Group in a $2.8 billion cash-and-stock transaction, marking one of the largest deals in the rare-earths industry.&nbsp;
- Psychedelic-linked firms like Compass Pathways (CMPS) skyrocketed after President Trump signed a weekend executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53% while AtaiBeckley surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% &mdash; touching its highest intraday level since July 2023.
- AST SpaceMobile (AST) shares dropped as much as 14% after Blue Origin&rsquo;s flagship New Glenn rocket failed to correctly place a satellite made by the Texas-based company in its intended orbit.

Closing Bell: USA Rare Earth Rises, Psychedelic-Linked Stocks Rally, AST SpaceMobile Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ca60d295-0702-4ca2-8503-b4320162732a/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

- QXO (QXO) shares fell nearly 9% after the company said it will acquire TopBuild Corp. for approximately $17 billion to create the second-largest publicly traded building products distributor in North America. Analysts are broadly positive on the deal, though some said it was unexpected.

- Compass Pathways (CMPS) saw its shares trade higher, along with other pharmaceutical businesses that have interests in psychedelic treatments after President Donald Trump signed an executive order to expedite research and access to psychedelics used outside the US to treat post-traumatic stress disorder. The order, signed in an Oval Office event on Saturday morning, directs the US Food and Drug Administration to issue new guidance to researchers on ibogaine, a psychedelic compound extracted from the iboga plant in Africa that’s used to treat depression, anxiety and PTSD for military veterans. The hallucinogen is considered a Schedule I controlled substance and is prohibited for use in the US. 

- Fermi (FRMI) plunged more than 20% Monday after a management shakeup that included the abrupt departure of its chief executive officer, potentially threatening its plans to build the world’s biggest private power grid for a data-center campus. The company co-founded by former US Energy Secretary Rick Perry is developing an AI campus in Texas that would initially be powered by natural gas, with plans to add as many as four nuclear reactors. But Fermi has been dogged by challenges in recent months, including the loss of a key anchor tenant for the site.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:&nbsp;
- QXO (QXO) shares fell nearly 9% after the company said it will acquire TopBuild Corp. for approximately $17 billion to create the second-largest publicly traded building products distributor in North America. Analysts are broadly positive on the deal, though some said it was unexpected.
- Compass Pathways (CMPS) saw its shares trade higher, along with other pharmaceutical businesses that have interests in psychedelic treatments after President Donald Trump signed an executive order to expedite research and access to psychedelics used outside the US to treat post-traumatic stress disorder. The order, signed in an Oval Office event on Saturday morning, directs the US Food and Drug Administration to issue new guidance to researchers on ibogaine, a psychedelic compound extracted from the iboga plant in Africa that&rsquo;s used to treat depression, anxiety and PTSD for military veterans. The hallucinogen is considered a Schedule I controlled substance and is prohibited for use in the US.&nbsp;
- Fermi (FRMI) plunged more than 20% Monday after a management shakeup that included the abrupt departure of its chief executive officer, potentially threatening its plans to build the world&rsquo;s biggest private power grid for a data-center campus. The company co-founded by former US Energy Secretary Rick Perry is developing an AI campus in Texas that would initially be powered by natural gas, with plans to add as many as four nuclear reactors. But Fermi has been dogged by challenges in recent months, including the loss of a key anchor tenant for the site.

QXO Falls, Compass Pathways Rises, Fermi Plunges

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/72f12585-0dc7-4f98-a834-b432013b122b/transcript

Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips